Auranofin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1739 publications
Three Thiol-Reactive Reagents drive Synergistic Lethality in Glioblastoma cells.
Journal: Research square
Published: July 29, 2026
Three Thiol-Reactive Reagents drive Synergistic Lethality in Glioblastoma cells.
Journal: Research square
Published: July 29, 2026
Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Tubulin as a well-established yet underexploited target: new opportunities for drugs repurposing?
Journal: Journal of drug targeting
Published: June 29, 2026
Multifunctional auranofin analogues: dual-targeting TSPO/TrxR gold(I) complexes with activity in resistant ovarian cancer.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: May 29, 2026
Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase-1 Expression via the aPKC-NF-κB Pathway.
Journal: International journal of molecular sciences
Published: May 19, 2026
Mechanism of timosaponin AⅢ liposomes loaded with auranofin in inducing ferroptosis in anaplastic thyroid carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: May 18, 2026
Recent Advances in Anticancer Activity of Gold(I) Complexes.
Journal: Biomedicines
Published: May 08, 2026
Last Updated: 09/26/2026